Company intelligence
Biologit
One Platform. All Literature. Global and Local.
About Biologit
Biologit is the first and only technology company dedicated to global and local literature monitoring for pharmacovigilance (PV). Our AI-powered, GxP-validated platform supports pharmaceutical companies and CROs in meeting regulatory demands efficiently, transparently, and at scale. Built for the unique needs of PV teams, Biologit replaces fragmented systems with a single, intuitive platform that handles all relevant sources, from global open-access databases to regional, subscription-only, and print publications. With up to 70% efficiency gains, it frees PV professionals to focus on strategic safety decisions. Founded by PV expert Dr Nicole Baker and engineering leader Bruno Ohana, Biologit serves many of the world’s top 25 pharma companies across 170 countries.
Verified activity
Signals from Biologit
2 published signals
Presence & Recognition
Biologit CEO Nicole Baker PhD is attending the PIPA - Pharmaceutical Information and Pharmacovigilance Association Conference 2026 at the Denham Grove Hotel in Uxbridge, UK, alongside fellow panelist James Whitehead, Rory Littlebury, and Abidali Fazal.
Reported by Biologit
Presence & Recognition
Biologit celebrated International Overdose Awareness Day on 31 August with the theme 25 Years On. Still Needed.
Reported by Biologit